HBK Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,372
| Closed | -$300K | – | 293 |
|
|
2019
Q4 | $300K | Buy |
+1,372
| New | +$300K | ﹤0.01% | 230 |
|
|
2019
Q2 | – | Sell |
-25,339
| Closed | -$4.66M | – | 788 |
|
|
2019
Q1 | $4.66M | Sell |
25,339
-19,761
| -44% | -$3.63M | 0.05% | 244 |
|
|
2018
Q4 | $7.47M | Buy |
45,100
+30,712
| +213% | +$5.09M | 0.08% | 173 |
|
|
2018
Q3 | $2.77M | Sell |
14,388
-82,502
| -85% | -$15.9M | 0.02% | 356 |
|
|
2018
Q2 | $16.5M | Buy |
96,890
+68,690
| +244% | +$11.7M | 0.11% | 81 |
|
|
2018
Q1 | $4.6M | Sell |
28,200
-108,505
| -79% | -$17.7M | 0.03% | 265 |
|
|
2017
Q4 | $20.5M | Sell |
136,705
-23,895
| -15% | -$3.58M | 0.16% | 60 |
|
|
2017
Q3 | $24.4M | Buy |
160,600
+94,921
| +145% | +$14.4M | 0.15% | 43 |
|
|
2017
Q2 | $8.46M | Buy |
65,679
+62,079
| +1,724% | +$8M | 0.05% | 139 |
|
|
2017
Q1 | $394K | Buy |
+3,600
| New | +$394K | ﹤0.01% | 490 |
|
|
2016
Q3 | – | Sell |
-4,824
| Closed | -$415K | – | 969 |
|
|
2016
Q2 | $415K | Sell |
4,824
-99,476
| -95% | -$8.56M | ﹤0.01% | 722 |
|
|
2016
Q1 | $8.29M | Buy |
104,300
+55,954
| +116% | +$4.45M | 0.08% | 131 |
|
|
2015
Q4 | $6.08M | Buy |
48,346
+220
| +0.5% | +$27.7K | 0.06% | 139 |
|
|
2015
Q3 | $5.01M | Buy |
48,126
+12,460
| +35% | +$1.3M | 0.05% | 172 |
|
|
2015
Q2 | $4.4M | Sell |
35,666
-38,818
| -52% | -$4.79M | 0.04% | 196 |
|
|
2015
Q1 | $8.79M | Sell |
74,484
-71,216
| -49% | -$8.4M | 0.08% | 102 |
|
|
2014
Q4 | $17.3M | Buy |
145,700
+102,000
| +233% | +$12.1M | 0.21% | 49 |
|
|
2014
Q3 | $4.91M | Buy |
+43,700
| New | +$4.91M | 0.08% | 159 |
|
|
2014
Q2 | – | Sell |
-72,400
| Closed | -$5.12M | – | 1008 |
|
|
2014
Q1 | $5.12M | Buy |
+72,400
| New | +$5.12M | 0.09% | 130 |
|
|
2013
Q4 | – | Sell |
-111,530
| Closed | -$8.46M | – | 994 |
|
|
2013
Q3 | $8.46M | Buy |
111,530
+68,223
| +158% | +$5.17M | 0.12% | 66 |
|
|
2013
Q2 | $3.46M | Buy |
+43,307
| New | +$3.46M | 0.05% | 167 |
|